Peter Bronsert

33PUBLICATIONS
150CO-AUTHORS
Predictive and prognostic markersHaematological tumoursMedical infection agents (incl. prions)Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Mar 24, 2026
Proteomic characterization of intrahepatic cholangiocarcinoma identifies risk-stratifying subgroups and EIF4A1 as a therapeutic target.

Tilman Werner, Johanna Thiery, Klara-Luisa Budau

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Apr 14, 2025
The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer.

Konrad Kurowski, Sophie Nicole Prozmann, António Eduardo Cabrita Figueiredo

|Feb 24, 2025
MCAM is a prognostic biomarker in patients with liver cirrhosis and HCC.

Eva Stockinger, Hendrik Luxenburger, Dominik Bettinger

|Jan 22, 2025
Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer.

Jens Hoeppner, Thomas Brunner, Claudia Schmoor

|Dec 27, 2024
AI-Assisted High-Throughput Tissue Microarray Workflow.

Konrad Kurowski, Sylvia Timme, Melanie Christine Föll

Pageof 6

Frequent Collaborators

4 joint publications

Ulrich Friedrich Wellner

4 joint publications

Konrad Kurowski

3 joint publications

Maximilian Seidl

3 joint publications

Severin Schmid